Author details

Full Name

Michele Donato

Affiliation

ORCID

Career Start Year

1998

Papers

106

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37251903	Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors.		2023
36243045	Differential Diagnosis of Hematologic and Solid Tumors Using Targeted Transcriptome and Artificial Intelligence.	American Journal of Pathology	2023
36260735	Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients.	Blood advances	2023
37606045	Ancestry-based differences in the immune phenotype are associated with lupus activity.	JCI Insight	2023
36653124	Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation.	Ann Rheum Dis	2023
36571819	Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD.	J Crohns Colitis	2023
36696483	Malaria-driven expansion of adaptive-like functional CD56-negative NK cells correlates with clinical immunity to malaria.	Sci Transl Med	2023
35346346	An 8-gene machine learning model improves clinical prediction of severe dengue progression.	Genome Med	2022
35905725	Rapid GPR183-mediated recruitment of eosinophils to the lung after Mycobacterium tuberculosis infection.	Cell Rep	2022
35277696	Author Correction: The immunoregulatory landscape of human tuberculosis granulomas.	Nat Immunol	2022
35042868	A 6-mRNA host response classifier in whole blood predicts outcomes in COVID-19 and other acute viral infections.	Sci Rep	2022
35248777	Sustained Hematopoietic Engraftment Potential after Prolonged Storage of Cryopreserved Hematopoietic Stem Cells Used in Salvage Autologous Stem Cell Transplantation.	Transplantation and Cellular Therapy	2022
34446466	Macrophage-derived IL-6 trans-signalling as a novel target in the pathogenesis of bronchopulmonary dysplasia.	Eur Respir J	2022
35139913	Cytokine signatures differentiate systemic sclerosis patients at high versus low risk for pulmonary arterial hypertension.	Arthritis Res Ther	2022
35058616	The immunoregulatory landscape of human tuberculosis granulomas.	Nat Immunol	2022
34944883	Comparison of the Transcriptomic Signatures in Pediatric and Adult CML.	Cancers (Basel)	2021
34017121	Repression of CTSG, ELANE and PRTN3-mediated histone H3 proteolytic cleavage promotes monocyte-to-macrophage differentiation.	Nat Immunol	2021
33965177	Safety and Efficacy of Consolidation Therapy with Ipilimumab Plus Nivolumab after Autologous Stem Cell Transplantation.	Transplantation and Cellular Therapy	2021
34174187	The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination.	Cell	2021
33952674	iPSC-endothelial cell phenotypic drug screening and in silico analyses identify tyrphostin-AG1296 for pulmonary arterial hypertension.	Sci Transl Med	2021
33571168	Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma.	JCI insight	2021
34137024	Immune tolerance with combined allogeneic haplo-identical haematopoietic stem cell transplant and renal transplant.	British Journal of Haematology	2021
33765435	Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses.	Immunity	2021
34435374	Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high-risk multiple myeloma.	Am J Hematol	2021
34714894	Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma.	PLoS Pathogens	2021
32727916	Cellular senescence impairs the reversibility of pulmonary arterial hypertension.	Sci Transl Med	2020
32160077	Treatment of Smoldering Myeloma: Problems With Study Design as well as Biological and Clinical Implications.	Journal of Clinical Oncology	2020
31101891	A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma.	Bone Marrow Transplantation	2019
30107138	FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension.	Am J Respir Crit Care Med	2019
31332045	Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD.	Blood advances	2019
29537985	Unsupervised Analysis of Transcriptomics in Bacterial Sepsis Across Multiple Datasets Reveals Three Robust Clusters.	Crit Care Med	2018
29960011	Single-cell epigenetics - Chromatin modification atlas unveiled by mass cytometry.	Clin Immunol	2018
29451944	Total Hip Arthroplasty in Patients With Avascular Necrosis After Hematopoietic Stem Cell Transplantation.	Orthopedics	2018
29706550	Single-Cell Chromatin Modification Profiling Reveals Increased Epigenetic Variations with Aging.	Cell	2018
29367465	Inflammatory macrophage-associated 3-gene signature predicts subclinical allograft injury and graft survival.	JCI Insight	2018
27590107	A Phase I/II Study of Escalating Doses of Bortezomib in Conjunction with High-Dose Melphalan as a Conditioning Regimen for Salvage Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma.	Biology of Blood and Marrow Transplantation	2016
27522040	Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.	Biology of Blood and Marrow Transplantation	2016
26416896	Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution.	Annals of Oncology	2015
24792872	The graft-versus-myeloma effect: chronic graft-versus-host disease but not acute graft-versus-host disease prolongs survival in patients with multiple myeloma receiving allogeneic transplantation.	Biology of Blood and Marrow Transplantation	2014
24661044	Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma.	British Journal of Haematology	2014
23426943	Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.	Blood	2013
21897398	Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation.	Bone Marrow Transplantation	2011
20581887	Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma.	Bone Marrow Transplantation	2011
20351328	Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.	Journal of Clinical Oncology	2010
18541718	Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vbeta use: a new paradigm for designer allogeneic blood and marrow transplantation.	Blood	2008
17382251	Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.	Biology of Blood and Marrow Transplantation	2007
17382253	Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.	Biology of Blood and Marrow Transplantation	2007
16399600	Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?	Biology of Blood and Marrow Transplantation	2006
16179379	Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation.	Blood	2006
16923559	High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma.	Leukemia and Lymphoma	2006